Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
09/2003
09/16/2003CA2119463C Glial cell line-derived neutrophic factor
09/16/2003CA2090860C Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures
09/12/2003WO2003074087A1 Coupling proteins to a modified polysaccharide
09/12/2003WO2003074001A2 Methods for designing specific inhibitors for pin1 proline isomerase and pin1-related molecules
09/12/2003WO2003018596A3 Method for removing endotoxins from protein solutions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002027317A3 Conjugates of defined stoichiometry
09/12/2003WO2002002488A9 Methods and compounds for modulating nuclear receptor coactivator binding
09/12/2003CA2754415A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2754041A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/11/2003US20030171560 Filtering through a semipermeable membranes, only low molecular weight with small diameter can pass through
09/11/2003US20030171559 A colony-stimulating factor hybrid molecules, computer analyzing the three dimensional structure protein, crystallization of the protein
09/11/2003US20030171550 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030171548 Immunoreactive proteins where the percentage of immuno-reactive molecules as determined in a modified Lindmo-test is >81%; fermentation of culture of fluidized reactor; diagnosis of inflammatory and bone marrow displacing process
09/11/2003US20030171536 Solid phase synthesis by the condensation of three partial fragments being carried out between the amino acid positions Glycine 108 and Arg 109 and amino acid positions Gly 120 and Cys 121; cyclization; deblocking; side-effects reduction
09/11/2003US20030171304 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
09/11/2003US20030171300 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. The pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary
09/11/2003US20030170840 Genomic mammary amyloid a sequence
09/11/2003US20030170815 Method for purifying recombinant proteins expressed as insoluble aggregates
09/11/2003US20030170810 Producing a cell lysate by adding detergent to the culture and sonicating; automated process control systems; filtration and concentration; high-throughput
09/11/2003US20030170790 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170789 Of given amino acid sequence; use in modulating cell activity, stimulating release of tumor necrosis factor, proteoglycans and cytokines; detecting tumors
09/11/2003US20030170788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/11/2003US20030170763 Protein antiallergens
09/11/2003US20030170749 Detection using antibodies; parasiticides; veterinary medicine
09/11/2003US20030170723 Depositing on a substrate an array of a first protein, applying a second protein over first protein and fused together; used to drug screening
09/11/2003US20030170641 Methods for screening for transdominant effector peptides and RNA molecules
09/11/2003US20030170474 Substrate for protein microarray containing functionalized polymer
09/10/2003EP1341932A2 Improved methods for gene expression monitoring on electronic microarrays
09/10/2003EP1341921A2 Hydrolases
09/10/2003EP1341806A1 Method and apparatus for separating biological molecules
09/10/2003EP1341802A1 In vitro protein synthesis using glycolytic intermediates as an energy source
09/10/2003EP1296948B1 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
09/10/2003EP0783299B1 Compounds and compositions for delivering active agents
09/10/2003CN1441806A Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
09/10/2003CN1441680A Cyclodextrin containing glycopeptide antibiotic pharmaceutical compositions
09/10/2003CN1120845C Process for separating and extracting nisin from fermented liquid
09/09/2003US6617435 Infiltrating a plant tissue with a buffer solution; subjecting plant tissue and buffer solution to a substantially vacuum environment; removing tissue from the buffer solution; centrifuging the tissue to remove interstitial fluid;
09/09/2003US6617423 Lactam bridge between aspartic acid and orinithine; increased conformational stability; useful in treatment of osteoporosis, Paget's disease or hypercalcemia
09/09/2003US6617134 Dimer of molecular variant of apolipoprotein and processes for the production thereof
09/09/2003US6617114 Identification of drug complementary combinatorial libraries
09/09/2003CA2187901C Improved method for the preparation of an aspartame-derived compound useful as a sweetener
09/09/2003CA2130174C 4-oxo-2 thioxoimidazolidine derivatives as inhibitors of blood platelet aggregation
09/09/2003CA2101648C Polysaccharide-protein conjugates
09/04/2003WO2003089641A2 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
09/04/2003WO2003073238A2 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
09/04/2003WO2003073106A2 Binding of pathological forms of prion proteins
09/04/2003WO2003072709A2 Variant tat proteins and methods for use thereof
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003072597A1 Intermediates and methods for making heptapeptide oxytocin analogues
09/04/2003WO2003072352A1 Porous compositions comprising surface modified monoliths
09/04/2003WO2003072054A2 Custom ligand design for biomolecular filtration and purification for bioseperation
09/04/2003WO2003072017A2 Macromolecular conjugates and processes for preparing same
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003029270A3 Process for preparing glycopeptide phosphonate derivatives
09/04/2003WO2003001212A3 A method for diagnosing a person having multiple sclerosis
09/04/2003WO2002083853A3 Method for enhancing the translation and expression of recombinant proteins
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002063288A8 Microfluidic devices
09/04/2003WO2002044143A3 Microcapillary arrays for high-throughput screening and separation of differently charged molecules using an electric field
09/04/2003WO2002032943A9 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
09/04/2003WO2002020769A9 Human and mouse targeting peptides identified by phage display
09/04/2003WO2001058925A3 Protein separation and display
09/04/2003US20030167129 Antiinflammatory agents; detecting binding to cellular library; separation; calibration
09/04/2003US20030166960 Method of purifying a hydrophobin present in a hydrophobin-containing solution
09/04/2003US20030166878 Magnetic carrier capable of binding with protein and purification method of protein utilizing the magnetic carrier
09/04/2003US20030166877 Reducing the immunogenicity of fusion proteins
09/04/2003US20030166869 Chromatography separation using apatite
09/04/2003US20030166848 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
09/04/2003US20030166832 Methods and compositions for impairing multiplication of HIV-1
09/04/2003US20030166580 Substituted amino carboxamides for the treatment of alzheimer's disease
09/04/2003US20030166194 Of given sequence; genetic mapping; anticoagulants
09/04/2003US20030166132 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166102 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166101 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166100 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166098 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166096 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166095 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166094 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166093 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166092 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166091 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166090 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166089 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166088 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166087 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166086 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166085 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166084 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166083 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166082 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166081 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166080 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166078 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same